From: Becker's Supply Chain Report <editorial@beckershealthcare.com>
Subject: FDA pulls pelvic mesh from market | Death of La. nurse attacked by patient ruled a homicide | Sterilization plant closure stalls device deliveries nationwide | Amgen's bone drug gets $22K price tag
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube


April 17, 2019
TODAY'S TOP STORIES
1. FDA orders removal of pelvic mesh products from market
 
2. Death of Louisiana nurse attacked by patient ruled a homicide Full story

3. How Nationwide Children's quietly became a leader in gene therapy Full story

4. Key steps to standardizing surgical packs Learn more

5. Medical device deliveries stalled after sterilization plant closed Full story 

6. Las Vegas hospital doesn't contract with any payers
 
7. Learn 4 ways to achieve success in clinical product standardization in this upcoming webinar. 

8. Allergan can't use Native American tribe to shield patents, Supreme Court rules
 
9. 50 companies investing in blockchain
 
10. Amgen's osteoporosis drug debuts with $22K annual price tag
  
11. How St. Vincent Medical Center is working toward sustainability with an AI-powered RCM solution. Click here to register for the webinar.

12. 10 hospitals seeking pharmacy leaders Full story


Channels
Contact Us

Editorial Contact: 
Molly Gamble 
Editor-in-Chief
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
 
Becker's Hospital Review
A Becker's Healthcare Publication
  www.BeckersHospitalReview.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact